InsidersTradesSigma
Follow the Imugene Limited stock price and the full insider trade history of the company, a listed equity based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, Imugene Limited has recorded 5 insider filings. Market capitalisation: €35.7m. The latest transaction was disclosed on 1 September 2026 (Other). Among the most active insiders: 2. Details of voting power. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Imugene Limited es una empresa biofarmacéutica centrada en el desarrollo de tratamientos inmunoterapéuticos para el cáncer. Cotiza en la Bolsa de Valores de Australia bajo el símbolo IMU.